An ExploratorYOLT-204(β)y Clinical Study to Evaluate the Safety and Efficacy of YOLT-204 in the Treatment of Hemoglobinopathies (Transfusion-Dependent β-Thalassemia and Sickle Cell Disease)
An open-label, single-dose, dose-escalation study to evaluate the safety and tolerability of YOLT-206 in patients with transthyretin amyloid cardiomyopathy (ATTR-CM)
100 项与 YOLT-206 相关的专利(医药)